Tenon Medical (TNON) Liabilities and Shareholders Equity (2021 - 2026)

Tenon Medical's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 4.15% year-over-year to $12.8 million; the TTM figure through Mar 2026 stood at $45.1 million (up 6.61% YoY), while the FY2025 annual figure was $10.8 million, up 9.32% from the prior year.
• Liabilities and Shareholders Equity was $12.8 million for Q1 2026 at Tenon Medical, up from $10.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $18.1 million in Q2 2022 to a low of $6.0 million in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $10.5 million across 5 years, with a median of $10.4 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity plunged 51.01% in 2023, then surged 85.05% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $11.1 million in 2022, then tumbled by 42.78% to $6.3 million in 2023, then jumped by 55.13% to $9.8 million in 2024, then climbed by 9.32% to $10.8 million in 2025, then increased by 19.31% to $12.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $12.8 million (Q1 2026), $10.8 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.